Literature DB >> 103

[Combined effects of hypoxia and hypercapnia on the functional state of the respiratory center].

A M Kulik, L N Kondrat'eva.   

Abstract

Experiments were conducted on cats under nembutal anesthesia; a study was made of pulse activity of bulbar respiratory neurons, electrical activity of the diaphragm and of the intercostal muscles; pO2, pCO2, pH, arterial blood oxygen saturation were determined in combined action of hypoxia and hypercapnia. When hypoxic gaseous mixture was given for respiration the developing hypocapnia disturbed the discharge rhythmic activity of the respiratory neurons, the respiration acquiring a pathological character of the Cheyne--Stokes type. After addition to the hypoxic gaseous mixture of 2% CO2 the gaseous composition of the arterial blood approached the initial values; this addition prevented the development of hypercapnia and disturbances of rhythmic discharge activity of the respiratory neurons. Addition of 5% CO2 to the hypoxic gaseous mixture produced a negative effect: at first it intensified and then depressed the pulse activity of the respiratory neurons, caused metabolic and respiratory acidosis, and promoted asphyxia.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 103

Source DB:  PubMed          Journal:  Biull Eksp Biol Med        ISSN: 0365-9615


  8 in total

1.  Allergic granulomatosis, allergic angiitis, and periarteritis nodosa.

Authors:  J CHURG; L STRAUSS
Journal:  Am J Pathol       Date:  1951 Mar-Apr       Impact factor: 4.307

Review 2.  Vasculitic neuropathies: an update.

Authors:  Kenneth C Gorson
Journal:  Neurologist       Date:  2007-01       Impact factor: 1.398

3.  The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis).

Authors:  A T Masi; G G Hunder; J T Lie; B A Michel; D A Bloch; W P Arend; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt
Journal:  Arthritis Rheum       Date:  1990-08

4.  Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome.

Authors:  Régis Sablé-Fourtassou; Pascal Cohen; Alfred Mahr; Christian Pagnoux; Luc Mouthon; David Jayne; Daniel Blockmans; Jean-François Cordier; Philippe Delaval; Xavier Puechal; Dominique Lauque; Jean-François Viallard; Abdelkader Zoulim; Loïc Guillevin
Journal:  Ann Intern Med       Date:  2005-11-01       Impact factor: 25.391

5.  Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients.

Authors:  L Guillevin; P Cohen; M Gayraud; F Lhote; B Jarrousse; P Casassus
Journal:  Medicine (Baltimore)       Date:  1999-01       Impact factor: 1.889

6.  Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists.

Authors:  Karina A Keogh; Ulrich Specks
Journal:  Am J Med       Date:  2003-09       Impact factor: 4.965

Review 7.  Pulmonary angiitis and granulomatosis revisited.

Authors:  A Churg
Journal:  Hum Pathol       Date:  1983-10       Impact factor: 3.466

Review 8.  Churg-Strauss syndrome: 2005-2008 update.

Authors:  Rafael G Grau
Journal:  Curr Rheumatol Rep       Date:  2008-12       Impact factor: 4.592

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.